111 related articles for article (PubMed ID: 1716605)
1. Antithrombotic effects of recombinant hirudin in different animal models.
Just M; Tripier D; Seiffge D
Haemostasis; 1991; 21 Suppl 1():80-7. PubMed ID: 1716605
[TBL] [Abstract][Full Text] [Related]
2. Studies on antithrombotic effects of recombinant hirudin.
Markwardt F; Kaiser B; Nowak G
Thromb Res; 1989 Jun; 54(5):377-88. PubMed ID: 2772864
[TBL] [Abstract][Full Text] [Related]
3. Effects of different hirudins and combinations of low doses of hirudin, heparin and acetylsalicylic acid in a rat microcirculatory thrombosis model.
Krupinski K; Breddin HK
Haemostasis; 1991; 21 Suppl 1():88-92. PubMed ID: 1894199
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic activity of recombinant hirudin in the rat: a comparative study with heparin.
Doutremepuich C; Deharo E; Guyot M; Lalanne MC; Walenga J; Fareed J
Thromb Res; 1989 Jun; 54(5):435-45. PubMed ID: 2772867
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic action of recombinant hirudin in a venous thrombosis model.
Raake W; Klauser RJ; Elling H; Zeiller P
Haemostasis; 1991; 21 Suppl 1():127-32. PubMed ID: 1654293
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the antithrombotic effect of the new recombinant hirudin HBW 023 and heparin in small arteries and veins.
Zhang B; Wieslander JB
Microsurgery; 1996; 17(2):89-96. PubMed ID: 8914063
[TBL] [Abstract][Full Text] [Related]
7. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
[TBL] [Abstract][Full Text] [Related]
8. Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin.
Agnelli G; Renga C; Weitz JI; Nenci GG; Hirsh J
Blood; 1992 Aug; 80(4):960-5. PubMed ID: 1498336
[TBL] [Abstract][Full Text] [Related]
9. Experimental pharmacology of hirunorm: a novel synthetic peptide thrombin inhibitor.
Cirillo R; Lippi A; Subissi A; Agnelli G; Criscuoli M
Thromb Haemost; 1996 Sep; 76(3):384-92. PubMed ID: 8883275
[TBL] [Abstract][Full Text] [Related]
10. Superior activity of a thromboxane receptor antagonist as compared with aspirin in rat models of arterial and venous thrombosis.
Schumacher WA; Heran CL; Steinbacher TE; Youssef S; Ogletree ML
J Cardiovasc Pharmacol; 1993 Oct; 22(4):526-33. PubMed ID: 7505353
[TBL] [Abstract][Full Text] [Related]
11. Comparative study on the antithrombotic efficacy of hirudin, heparin and a low-molecular weight heparin in preventing experimentally induced venous thrombosis.
Monreal M; Galego G; Monreal L; Angles AM; Monasterio J; Oller B
Haemostasis; 1993; 23(3):179-83. PubMed ID: 8276322
[TBL] [Abstract][Full Text] [Related]
12. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits.
Agnelli G; Pascucci C; Cosmi B; Nenci GG
Thromb Haemost; 1990 Apr; 63(2):204-7. PubMed ID: 2363121
[TBL] [Abstract][Full Text] [Related]
13. A technique to investigate microvascular mural thrombus formation in arteries and veins: II. Effects of aspirin, heparin, r-hirudin, and G-4120.
Stockmans F; Stassen JM; Vermylen J; Hoylaerts MF; Nyström A
Ann Plast Surg; 1997 Jan; 38(1):63-8. PubMed ID: 9015542
[TBL] [Abstract][Full Text] [Related]
14. The antithrombotic and anticoagulant effects of a synthetic tripeptide and recombinant hirudin in various animal models.
Bacher P; Walenga JM; Iqbal O; Bajusz S; Breddin K; Fareed J
Thromb Res; 1993 Aug; 71(4):251-63. PubMed ID: 8236155
[TBL] [Abstract][Full Text] [Related]
15. Determination of the dosage of recombinant hirudin to inhibit arterial thrombosis in baboons.
Kotzé HF; Lamprecht S; Van Wyk V; Roodt JP; Badenhorst PN
J Pharm Sci; 2000 May; 89(5):579-85. PubMed ID: 10756323
[TBL] [Abstract][Full Text] [Related]
16. Prevention of early reocclusion after thrombolysis of copper coil-induced thrombi in the canine carotid artery: comparison of PEG-hirudin and unfractionated heparin.
Rübsamen K; Hornberger W
Thromb Haemost; 1996 Jul; 76(1):105-10. PubMed ID: 8819261
[TBL] [Abstract][Full Text] [Related]
17. Prevention of experimental venous thrombosis in rabbits with different low molecular weight heparins, dermatan sulphate and hirudin.
Matthiasson SE; Lindblad B; Bergqvist D
Haemostasis; 1995; 25(3):124-32. PubMed ID: 7607580
[TBL] [Abstract][Full Text] [Related]
18. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
19. Effect of recombinant hirudin (LU 52369) on reocclusion rates after thrombolysis in rabbits.
Rübsamen K; Eschenfelder V
Haemostasis; 1991; 21 Suppl 1():93-8. PubMed ID: 1894200
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of three recombinant hirudins with heparin in an experimental venous thrombosis model.
Doutremepuich C; Lalanne MC; Doutremepuich F; Walenga J; Fareed J; Breddin HK
Haemostasis; 1991; 21 Suppl 1():99-106. PubMed ID: 1894201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
